Clinical Trial Update: Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis

View source ↗

Summary

This clinical trial update notes that the study on nitric oxide lung diffusing capacity in systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Holger Dressel | Conditions: Systemic Sclerosis | Status: COMPLETED